Long-term survival in patients with brain metastases—clinical characterization of a rare scenarioMichèle Hugel, Clemens Seidel, Jiřı́ Stöhr et al.|Strahlentherapie und Onkologie|2023Cited by 12
Diabetes Mellitus Is a Strong Independent Negative Prognostic Factor in Patients with Brain Metastases Treated with RadiotherapySeong Hoon Jeong, Clemens Seidel, Sabine Klagges et al.|Cancers|2023Cited by 2
Short-term survivors with brain metastases have modest benefits from focal and systemic therapies and remain frequent despite improving treatment landscapeM. Czogalla, Clemens Seidel, Jiřı́ Stöhr et al.|Clinical and Translational Radiation Oncology|2025Cited by 2
Hyperglycemia is associated with poor survival in patients with brain metastases treated with radiotherapySoniya Poudyal, Clemens Seidel, Friederike Rothe et al.|Strahlentherapie und Onkologie|2025Cited by 1
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantationGeorg‐Nikolaus Franke, Madlen Jentzsch, Jule Ussmann et al.|Bone Marrow Transplantation|2025Cited by 0